Gilead Raday, Chief Operating Officer at RedHill Biopharma Ltd. (RDHL), sold 15,740,000 shares at $0.00 ($2K) on 2026-04-06, disclosed to the SEC on 2026-04-22.
Open-market sale of $2k RDHL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |